Eli Lilly (LLY) just dropped over 20% — but is it panic or opportunity? In this episode of Am I Catching a Falling Knife?, we dissect the GLP-1 drama, break down the earnings impact, and run valuation models to see if this pharma giant is oversold or overhyped.

🔍 Topics covered:

What happened with orforglipron

How investor sentiment affects earnings

DCF vs PEG valuation breakdown

📉 Not financial advice — just sharp analysis with a satirical edge.

Subscribe for more breakdowns of market meltdowns and meme stock madness.

#stockanalysis #stockmarket #stockcrash